GLP-1 Healthy Weight Study

A Parallel-Group, Double-Blind Study to Investigate the Safety and Tolerability of a GLP-1 Product Compared with Placebo in Adult Participants Aged 55 to 80 Years with a BMI of 22 to 25 kg/m2.

 

The study involves up to 20 visits to our clinic in Guelph, ON. You may be in the study for up to 60 weeks including a screening period (up to 8 weeks), a treatment period (48 weeks) and a follow-up period (4 weeks). If you do not complete a pre-screening, there will be 19 visits. You will receive reasonable compensation for your time and travel to the clinic. 

 

The primary purpose of this study is to assess the safety and tolerability of a new investigational drug compared to placebo (inactive product). In addition, this study will assess changes in weight and body composition, physical mobility, health-related quality of life, lipid levels, glycemic control, and cognitive health

Only a limited amount of spots available.

You may be eligible if you are:

Age

Between 55 to 80 years old

BMI

Have a BMI between 22 to 25kg/m2

Healthy

In good general health

No meds

NOT taking any medications/supplements for the promotion of weight loss or weight gain

Willing

Have a stable body weight (over past 3 months)

GLP-1 Healthy Weight Study

Participation will include:

  • Up to 20 visits to our clinic (Guelph, ON)
  • 48 weeks of oral study product consumption
  • Blood draws 
  • 3 body composition scans (to assess body fat and lean mass)
  • 2 Oral Glucose Tolerance Tests
  • Fasting prior to all in-clinic visits 

How it works:

Facility Features

We take pride in our bright, modern clinic that we continue to upgrade to ensure a comfortable clinical trial experience for you. Click here to take a virtual tour of our space.

Free wifi available throughout facility

Accessible facility

Private rooms available for calls

Certified, experienced and friendly staff

Comfortable seating options

24/7 access to staff

The Team Behind the Scenes

At Apex Trials, your safety is our top priority. Our team of qualified staff are here to ensure everything runs smoothly.

Dr. Anthony Bier

Dr. Anthony Bier
Medical Director

Neuza Pereira

Neuza Pereira
Clinical Research Coordinator I

Terrie Davenport

Terrie Davenport
Clinical Research Coordinator II

Keara Canney

Keara Canney
Lead Participant Recruiter

Full Team

Think you'd be interested in joining the study?

Complete Pre-screening Questionnaire